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Purpose: To evaluate the clinical outcomes obtained after cataract or crystalline 
lens surgery with implantation of a new continuous transitional focus (CTF) intraocular 
lens (IOL). 
Setting: San Rafael Hospital, Madrid, Spain 
Design: Non-randomized prospective case series 
Methods: Sixty-two eyes of 31 patients (mean age: 61.3 years) were enrolled. In 
all cases, uncomplicated phacoemulsification catarac  surgery was performed with 
bilateral implantation of the CTF IOL Precizon Presbyopic (Ophtec BV, Groningen, 
The Netherlands). Visual, refractive, and contrast sensitivity outcomes were evaluated 
during a 6-month follow-up. Likewise, the incidence of postoperative disturbing photic 
phenomena was recorded. 
Results: Mean 6-month postoperative binocular uncorrected distance (UDVA), 
intermediate (UIVA) and near visual acuity (UNVA) were 0.01 ± 0.03, 0.17 ± 0.04, and 
0.02 ± 0.04 logMAR, respectively. A total of 98.4% and 93.5% of eyes achieved 20/25 
monocular UDVA and UNVA or better, respectively, whereas all eyes (100%) achieved 
20/30 UIVA or better. Mean corrected visual acuity of 0.14 ± 0.05, 0.15 ± 0.06, and 
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month postoperative log contrast sensitivity was 1.22 ± 0.18 and 0.75 ± 0.10 for 12 and 
18 cycles/º. A total of 9.7% and 6.5% of patients reported disturbing halos and glare. 
Conclusions: This presbyopia-correcting IOL provides a complete visual 
rehabilitation after cataract surgery, maintaining excellent levels of visual quality. 
Specifically, the IOL generates a continuous range of functional vision from distance to 
near, with minimal levels of photic phenomena associated.  
Keywords: presbyopia; cataract surgery; Precizon presbyopic; continuous 






 Multifocal intraocular lens (IOL) implantation after cataract surgery has shown 
to be an effective therapeutic option to achieve postoperative spectacle-independence 
and functional vision.1 Despite the technological advances in IOL technology, some 
limitations and disadvantages have been also describ d for different models of 
multifocality.1 One of the main disadvantages of multifocal IOLs is the induction of 
disturbing photic phenomena mainly due to the significant difference between in-focus 
and out-focus images projected on the retina.2,3 Indeed, this is one of the main causes of 
dissatisfaction after cataract surgery with multifocal IOL implantation.4 Extended depth 
of focus (EDOF) IOLs were developed to overcome this limitation by inducing a 
continuous range of focus, but with a not completely functional near vision compared to 
multifocal IOLs.5 Furthermore, with multifocal IOL implants, centration is a critical 
factor limiting the outcomes as a decentered multifocal IOL may induce significant 
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postoperative visual function. Likewise, some multifocal IOL designs have been shown 
to be pupil-dependent, with a significant variability n the outcomes depending on 
pupillary changes.6,7 A new concept of presbyopia-correcting intraocular lens (IOL) has 
been recently developed, the concept of continuous transitional focus (CTF), with the 
aim of overcoming some limitations and problems of the predecessor multifocal and 
EDOF IOLs.8 
CTF IOLs are based on obtaining a smoother transitio  between distance and 
near vision by combining different sectors in the optical zone of the IOL providing the 
distance and near vision correction.8 The first IOL developed and commercially 
released based on this CTF concept is the Precizon Presbyopic 570 A0 IOL (Ophtec 
BV, Groningen, The Netherlands) (Figure 1). Specifically, this IOL is divided into three 
concentric sectors, including a central factor of higher diameter that provides the 
distance correction, and two peripheral sectors presenting a bimodal distribution of 
distance and near correction, changing along four segments in each sector.8 The aim of 
the current study is to report for the first time th  clinical outcomes in terms of visual 
acuity, contrast sensitivity and photic phenomena obtained after conventional cataract 





This study was a non-randomized prospective case seri s including 62 eyes of 
31 patients with a mean age of 61.3 years. In all cases, uncomplicated 
phacoemulsification surgery was performed with bilater l implantation of the CTF IOL 
Precizon Presbyopic (Ophtec BV, Groningen, The Netherlands). All patients were 





 Copyright © 20 Published by Wolters Kluwer on behalf of ASCRS and ESCRS. Unauthorized reproduction of this article is prohibited.20 
 
 
The study adhered to the tenets of the Declaration of Helsinki and was approved by the 
hospital ethics committee. Inclusion criteria were patients with cataract or 
presbyopic/pre-presbyopic patients suitable for refactive lens exchange seeking for 
spectacle independence, and pre-existing corneal astigmatism below 1 D. Exclusion 
criteria included active or systemic ocular pathology, previous ocular surgery, 
antecedents of glaucoma, uveitis or retinal problems, irregular corneal astigmatism, and 
abnormal iris.  
 
Preoperative and postoperative examinations 
A complete preoperative ophthalmological examination was performed in all 
patients including measurement of monocular uncorreted (UDVA) and binocular 
corrected distance visual acuity (CDVA), manifest refraction, measurement of 
uncorrected near visual acuity (UNVA) at 40 cm, keratometry, Goldmann applanation 
tonometry, slit lamp examination, optical biometry (IOL Master v.4.3, Carl Zeiss 
Meditec, Jena, Germany), and indirect ophthalmoscopy.  
Postoperatively, patients were evaluated the day after surgery, as well as at 1 and 
6 months after surgery. UDVA measurement, tonometry and examination of the 
integrity of the anterior segment was performed the day after surgery. At 1 and 6 
months postoperatively, the following tests were performed: measurement of monocular 
and binocular UDVA, binocular CDVA, monocular and binocular UNVA at 40 cm, and 
monocular and binocular uncorrected intermediate visual acuity (UIVA) at 66 cm,  
evaluation of defocus curve to evaluate the range of functional function (defocus 
introduced in 0.5-D steps from +1.50 D to -5.00 D), and contrast sensitivity 
measurements under dim ambient light conditions (approx. 25 lux) (Advanced 
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Distance visual acuity and defocus curve measurements were performed at 2.45 m due 
to the spatial limitations of the examination room, with an adjustment of the optotype 
size according to this distance. These measurements were performed under dim ambient 
light conditions (approx. 25 lux), taking care that no reflections or light sources were 
dazzling the patient (Advanced Ophthalmic Charts, AOC, EYENEXT, Camburzano, 
Italy; test illumination 300 lux). Likewise, patients were asked orally if they perceived 
disturbing photic phenomena, including halos, glare and starbursts. 
Surgery 
All surgeries were performed by the same experienced surgeon (MR) using a 
standard technique of sutureless microincision phacoemulsification. Surgeries were 
initiated after instilling anaesthesia and mydriatic drops by performing a corneal incision 
at the temporal area. The procedure was followed with the creation of the capsulorhexis 
and the performance of the phacoemulsification. After this, the IOL was inserted into the 
capsular bag through the main incision using the injector developed by the manufacturer 
for this purpose. A capsular tension ring (CTR) was inserted in all cases before IOL, 
with a diameter of 12 mm for white-to-white (WTW) corneal diameters until 11.9 mm 
and with a diameter of 13 mm for eyes with WTW of 12 mm or more. A postoperative 
topical therapy based on a combination of topical antibiotic and steroid was prescribed to 
be applied four times daily for one week. 
 
Intraocular lens 
The 570 A0 Precizon Presbyopic IOL is a one-piece CTF IOL with a 6.0-mm 
optic, an overall length of 12.5 mm (Figure 1). It has open modified C-loops with offset 
shaped haptics. It is made of a hybrid material hydrophilic/hydrophobic acrylic material 
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This IOL provides the ability for a transition in focus between 11 distinct segments (five 
for distance and six for near vision), with the central segment dedicated for distance 
vision (x=2.0 mm, y=0.5 mm). The rotated segments have a width of 0.75 mm. The IOL 
is available in optic powers from 1.0 to 35.0 D (0.5-D increments), with a near addition 
of +2.75 D. The company labelled A-constant for this IOL is 118.6. In the current study, 
IOL power calculations were performed using the SRK-T formula considering the 
measurements of corneal power, axial length, and anterior chamber depth obtained with 
the optical biometer. Target refraction was emmetropia in all cases. 
 
Statistical analysis 
Statistical analyses were performed with a commercially available software 
package (SPSS for Mac, Version 20.0; IBM Corporation, Armonk, NY, USA). 
Normality of data samples was evaluated by means of the Kolmogorov-Smirnov test. 
When parametric analysis was possible, the Student t test for paired data was used for 
comparisons between consecutive visits, whereas the Wilcoxon ranked sum test was 
applied to assess the significance of such differences when parametric analysis was not 





A total of 62 eyes of 31 patients with mean age of 61.3 years (SD: 8.2, median: 
61.0, range: 48 to 83 years) were enrolled. The sample was comprised of 7 males 
(22.6%) and 24 females (77.4%). A calculation of the statistical power associated to the 
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GRANMO (http://www.imim.cat/ofertadeserveis/software-public/granmo), obtaining a 
value of 80% considering a paired comparison pre-post, UNVA as the main outcome 
measure, the standard deviation of differences in UNVA (preop-1 month postop, 0.33 
logMAR), an alpha error of 0.05 and a minimum detectable difference of 0.12 logMAR. 
According to this, the statistical power is enough to detect the presence of differences in 
UNVA with surgery that can be clinically relevant. 
Visual and refractive outcomes 
Table 1 summarizes the preoperative and postoperativ  visual and refractive 
data obtained in the whole sample. As shown, a significa t improvement was observed 
in monocular UDVA and UNVA as well as in binocular CDVA (p<0.001), with no 
significant changes afterwards (p≥0.157). At 1 and 6 months after surgery, a total of 
98.4% (61/62) and 93.5% (58/62) of eyes had a value of UDVA and UNVA of 20/25 or 
better, respectively (Figure 2). Likewise, a total of 93.5% (56/62) of eyes achieved a 
value of 20/30 or better of UIVA at 1 and 6 months after surgery (Figure 2).  
Binocularly, at 6 months postoperatively, a total of 100% (31/31) and 96.8% (30/31) of 
eyes achieved a value of UDVA and UNVA of 20/25 or better, respectively, whereas all 
eyes (31/31, 100%) achieved 20/30 UIVA or better (Figure 3). 
 
Binocular defocus curve outcomes 
Figure 3 shows the mean 1-month and 6-month postoperativ  binocular defocus 
curve in the sample evaluated. No statistically significant changes were found in the 
visual acuities measured for the different levels of defocus tested between the first and 
sixth postoperative month (p≥0.059), except for those corresponding to the defocus of -
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Contrast sensitivity outcomes 
Figure 5 shows the mean 1-month and 6-month postoperativ  binocular contrast 
sensitivity function in the sample evaluated. No signif cant changes in contrast 
sensitivity for any of the spatial frequencies evaluated were found between the first and 
the sixth postoperative month (p≥0.317). 
 
Photic phenomena 
At 1 and 6 months postoperatively, a total of 3 patients (9.7%, 3/31) reported the 
perception of disturbing halos. In contrast, the perception of disturbing glare was only 
reported by 2 patients at the two postoperative visits (6.5%, 2/31). The perception of 




In the current study, the CTF IOL evaluated has shown to provide excellent 
distance visual outcomes, with values of 6-month postoperative UDVA and CDVA 
comparable to those reported for monofocal and EDOF I Ls.5,9-14 Specifically, mean 
binocular logMAR UDVA and CDVA values of 0.01 ± 0.03 and 0.01 ± 0.02, 
respectively, were obtained in our series. These distance visual outcomes are also 
similar and even better than those reported with other ypes of multifocal IOLs.9-13,15-19 
Levinger et al15 evaluated 26 eyes undergoing femtosecond laser-assisted cataract 
surgery (FLACS) with implantation of a trifocal diffractive IOL, obtaining a mean 6-
month postoperative UDVA of 0.18 ± 0.32 logMAR. Mojzis et al19 obtained in a 
comparative study of eyes undergoing cataract surgery with implantation of a bifocal or 
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0.01 ± 0.13 and 0.02 ± 0.14 logMAR, respectively. Concerning visual quality, excellent 
distant contrast sensitivity outcomes were observed with the CTF IOL analyzed. 
Specifically, the values of dim light contrast sensitivity obtained were closer to those 
reported for monofocal and EDOF IOLs when compared to multifocal IOLs.12-14,19 
Future studies should be conducted if this trend is also observed for contrast sensitivity 
measured at near. 
Concerning intermediate visual outcomes, the CTF IOL evaluated showed 
monocular and binocular UIVA values of 0.19 ± 0.06 and 0.17 ± 0.04 logMAR, 
respectively. This outcome is consistent with that reported for intermediate vision with 
trifocal diffractive and low-addition bifocal diffractive IOLs.12-15,18,19 Levinger et al15 
and Mojzis et al19 found mean UIVA values of 0.17 ± 0.21 and 0.09 ± 0.11 logMAR at 
66 cm with two different types of trifocal diffractive IOL. Savini et al14 found mean 
DCIVA values of 0.08 ± 0.09 and 0.21 ± 0.12 logMAR in eyes implanted with a 
refractive EDOF and low-add multifocal IOLs, respectively. Likewise, intermediate 
visual outcomes obtained with the IOL evaluated were clearly superior to those reported 
for medium/high add bifocal diffractive IOLs.9,12,18,19 Indeed, Mojzis and colleagues19 
demonstrated that a bifocal diffractive IOL provided significantly worse UIVA results 
than a trifocal diffractive IOL based on the same platform (0.26 ± 0.17 vs. 0.09 ± 0.11 
logMAR, p<0.001). In our sample, a total of 90.3% of eyes achieved a 6-month 
postoperative UIVA of 20/30 or better, which is consistent with the results of previous 
series evaluating EDOF or trifocal diffractive IOLs.10,12 Cochener et al10 found in a 
sample of eyes implanted with a diffractive-based EDOF that 55% of eyes achieved a 
UIVA value of 20/30 or better at 6 months after surgery. Pedrotti et al12 found a 
percentage of eyes implanted with the same diffractive-based EDOF and achieving a 
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authors found that 94.0% and 6.0% of eyes implanted with a low and medium add 
multifocal IOL based on the same platform achieved postoperative UIVA of 20/25 or 
better.12  
The near visual outcomes obtained with the CTF evaluated were clearly superior 
to those reported with monofocal and EDOF IOLs,9-13 confirming the ability of this IOL 
of providing a functional and comfortable near vision. This may be considered as the 
main advantage of CTF IOLs over EDOF IOLs, although randomized comparative 
studies should be conducted to extract more consistent conclusions regarding this issue. 
Specifically, mean monocular and binocular UNVA values of 0.04 ± 0.05 and 0.02 ± 
0.04 logMAR were obtained in our series, respectively. Savini et al14 found DCNVA 
values of 0.35 ± 0.14 and 0.35 ± 0.13 logRAD in two gr ups of eyes implanted with a 
refractive-based EDOF and a low add diffractive IOL, respectively. Likewise, Pedrotti 
et al12 found mean DCNVA values of 0.18 ± 0.09 and 0.32 ± 0.10 logMAR in eyes 
implanted with a diffractive-based EDOF and a low-add multifocal IOL, respectively. 
Therefore, the CTF IOL evaluated provides clearly better near visual outcomes than 
EDOF IOLs, with UNVA and DCNVA values at 40 cm comparable to those obtained 
with trifocal diffractive IOLs.10-13,15 In our sample, a total of 93.5% of eyes achieved 6-
month postoperative monocular UNVA of 20/25 or better. Cochener and coauthors10 
reported in a comparative study that a total of 81.5%, 82.5% and 52.5% achieved a 6-
month postoperative UNVA of 20/30 or better with two different trifocal diffractive and 
a diffractive-based IOLs. 
The good distance, intermediate and near visual outcomes obtained with the 
CTF IOL evaluated were consistent with the defocus rve measured in the patients 
enrolled in the current study. The mean defocus curve showed a continuous range of 
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20/30. This visual behavior overcomes the limitation in near vision found and reported 
for EDOF and low add multifocal IOLs.12,16 Likewise, the CTF IOL evaluated avoids a 
marked decay in visual performance in the intermediat  range that can be observed with 
bifocal diffractive IOLs and even with some models of trifocal IOLs.12,18,19 Mean 
corrected visual acuities values for the defocus level of 1 D of 0.17 ± 0.09, 0.03 ± 0.06, 
0.14 ± 0.13 and 0.35 ± 0.11 logMAR for a monofocal, diffractive-based EDOF, low add 
diffractive and medium add multifocal IOLs, respectively. In our series, the mean 
corrected visual acuity for 1 D of defocus was 0.14 ± 0.05 logMAR. 
The perception of photic phenomena with the CTF IOLevaluated at the end of 
the follow-up was limited, with 9.7% and 6.5% of patients reporting disturbing halos 
and glare, respectively. This incidence of photic phenomena is similar to that reported 
with EDOF IOLs, developed by concept to reduce the size of halos and glare.10,14 
Sachdev et al20 reported that 94% of patients implanted in a serie of 50 patients 
implanted with a diffractive-based EDOF IOL perceived no or minimal photic 
phenomena such as glare and halos. Maxwell and coauthors21 found in a comparative 
study that ≥72% and ≥73% of patients did not experience blurred, distorted, or double 
vision after implantation of a monofocal and a low add diffractive multifocal IOLs. 
Likewise, our incidence of photic phenomena was clearly inferior to that reported for 
different types of bifocal and trifocal IOLs.22-25 Kretz et al24 reported a percentage of 
perception of mild halos of 18.2% in eyes implanted with a bifocal diffractive IOL. 
Mendicute et al23 confirmed that 25% of patients perceived bothering halos with a 
trifocal diffractive IOL. In this study, no clinical peculiarities were observed in the few 
cases referring the perception of photic phenomena. Possibly, differences in the 
mechanism of neuroadaptation between individuals may be the main factor contributing 
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The use of CTR in the current series should be also considered as another factor 
potentially contributing to the successful outcome obtained. Various studies have 
demonstrated the benefit of using these devices when implanting presbyopia-correcting 
IOLs in terms of optimized intraocular optical performance due to a better IOL stability 
within the capsular bag.26-28 Specifically, Mastropasqua et al26 confirmed that the 
implant of CTR combined with multifocal IOLs reduces the third-order aberration 
related to potential IOL misalignments and tilting. Future studies should be conducted 
to evaluate the level of tolerance of this type of IOL to decentrations and tilting in order 
to confirm the real need for the use of CTR. 
Finally, this study has several limitations that must be acknowledged. One of 
these limitations is the absence of a control group f eyes implanted with monofocal 
IOLs to perform a comparative analysis allowing theextraction of more consistent 
conclusions. Future randomized clinical trials must be conducted to compare the 
outcomes obtained with this new modality of IOL with those obtained with monofocal, 
EDOF and multifocal IOLs. This would allow determining the real benefits of this CTF 
IOL over other previously commercially released presbyopia-correcting IOLs. Another 
important limitation of this investigation is the mode of evaluating the perception of 
photic phenomena, without using a validated questionnaire for such purpose. Future 
studies must be performed using validating tools to confirm the preliminary outcomes 
obtained in the current series. Likewise, there are some aspects that could have been 
evaluated in the study for a better characterization of the performance of the CTF IOL 
evaluated, such as the measurement of contrast sensitivity at near, intraocular 
aberrometry, the level of scattering or the size of the light disturbances perceived. 
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In conclusion, the CTF IOL Precizon Presbyopic is a presbyopia-correcting 
implant that provides a complete visual rehabilitaton after cataract surgery, maintaining 
excellent levels of visual quality. Specifically, the IOL generates a continuous range of 
functional vision from distance to near, with minimal levels of photic phenomena 
associated. Future studies should be conducted to confirm if these results are maintained 
in the long term. 
 
WHAT WAS KNOWN 
*Multifocal IOLs are an effective option to provide postoperative spectacle-
independence and functional vision 
*One of the main disadvantages of multifocal IOLs is the induction of disturbing 
photic phenomena mainly due to the significant difference between in-focus and out-
focus images projected on the retina 
*Extended depth of focus IOLs were developed to overcome the photic 
phenomena problems associated to multifocal IOLs by inducing a continuous range of 
focus, but with some limitations in near vision performance 
*Some multifocal IOL designs are pupil-dependent, wi h a significant variability 
in the outcomes depending on pupillary changes 
 
WHAT THIS PAPER ADDS 
*The concept of continuous transitional focus (CTF) IOL is an option of implant 
in cataract surgery that provides a complete visual rehabilitation after cataract surgery, 
maintaining excellent levels of visual quality.  
*CTF IOLs generate a continuous range of functional vision from distance to 
near. 
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*Future studies should be conducted to compare CTF IOLs with multifocal and 
EDOF IOLs in order to confirm if this type of IOL overcomes the limitations associated 
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Figure 1.- Diagram of the optical design of the 570 A  Precizon Presbyopic 
intraocular lens. 
Figure 2.- Postoperative distribution of monocular uncorrected distance 
(UDVA), intermediate (UIVA), and near visual acuity (UNVA) 1 month after the 
implantation of the 570 A0 Precizon Presbyopic intraocular lens in the sample 
evaluated. The same distribution was observed at 6 months after surgery. 
Figure 3.- Postoperative distribution of binocular uncorrected distance (UDVA), 
intermediate (UIVA), and near visual acuity (UNVA) after the implantation of the 570 
A0 Precizon Presbyopic intraocular lens in the sample evaluated.  
Figure 4.- Mean 1-month and 6-month postoperative binocular defocus curve 
after the implantation of the 570 A0 Precizon Presbyopic intraocular lens in the sample 
evaluated.  
Figure 5.- Mean 1-month and 6-month postoperative binocular contrast 
sensitivity function after the implantation of the 570 A0 Precizon Presbyopic intraocular 
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Table 1.- Summary of preoperative and postoperative visual and refractive data in the sample evaluated. The 












1.00 (0.10 to 1.30) 
0.03 (0.04) 
0.05 (0.00 to 0.15) 
0.03 (0.04) 
0.04 (0.00 to 0.15) 
<0.001 (preop-1 month) 
0.999 (1-3 months) 
Binocular LogMAR 
UDVA 
--- 0.01 (0.02) 
0.00 (0.00 to 0.10) 
0.01 (0.03) 
0.00 (0.00 to 0.10) 




0.85 (0.00 to 1.30) 
0.04 (0.06) 
0.05 (0.00 to 0.22) 
0.04 (0.05) 
0.05 (0.00 to 0.22) 
<0.001 (preop-1 month) 
0.157 (1-3 months) 
Binocular LogMAR 
UNVA 
--- 0.02 (0.04) 
0.00 (0.00 to 0.15) 
0.02 (0.04) 
0.00 (0.00 to 0.15) 
0.999 (1-3 months) 
Monocular LogMAR 
UIVA 
--- 0.19 (0.06) 
0.15 (0.10 to 0.40) 
0.19 (0.06) 
0.15 (0.10 to 0.40) 
0.999 (1-3 months) 
Binocular LogMAR 
UIVA 
--- 0.17 (0.05) 
0.15 (0.10 to 0.30) 
0.17 (0.04) 
0.15 (0.10 to 0.22) 




0.05 (0.00 to 0.52) 
0.01 (0.02) 
0.00 (0.00 to 0.10) 
0.01 (0.02) 
0.00 (0.00 to 0.10) 
<0.001 (preop-1 month) 
0.999 (1-3 months) 
SE (D) --- -0.55 (0.50) 
-0.50 (-1.50 to 0.50) 
-0.54 (0.52) 
-0.50 (-1.50 to 0.50) 
0.180 (1-3 months) 
 Only preoperative data 
 
AL (mm) 23.47 (1.12) 








7.71 (7.16 to 8.54) 
WTW (mm) 11.98 (0.39) 
12.00 (10.90 to 12.70) 
IOL power (D) 20.48 (3.46) 
21.25 (11.50 to 25.00) 
 
*Abbreviations: SD, standard deviation; D, diopters; UDVA, uncorrected distance visual acuity; CDVA, 
corrected distance visual acuity; UIVA, uncorrected intermediate visual acuity; UNVA, uncorrected near visual 
acuity; CNVA, corrected near visual acuity; SE, spherical equivalent; AL, axial length; ACD, anterior chamber depth; 
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